Astrazeneca: An overview
Astrazeneca is a leading pharmaceutical company formed in 1999 through merger of Astra AB of Sweden and Zeneca group PLC of UK (www.astrazeneca.com). The world pharmaceuticals market was valued at $492 billion in 2004 (Astrazeneca annual report, 2004). Moreover with Astrazeneca pumping in almost $3.8 billion into research and development for new drugs in 2004 at the rate of $15 million per working day makes it an interesting and an ideal entity to analyse (Astrazeneca annual report, 2004).
In addition to the above facts, Astrazeneca being a pioneer in its field will definitely be an ideal entity to study and analyze. Companies in the big league are expected to adhere to the... [continues]
Cite This Essay
(2006, 04). Objective of Financial Statements- a Critical Review. StudyMode.com. Retrieved 04, 2006, from http://www.studymode.com/essays/Objective-Financial-Statements-Critical-Review-85068.html
"Objective of Financial Statements- a Critical Review" StudyMode.com. 04 2006. 04 2006 <http://www.studymode.com/essays/Objective-Financial-Statements-Critical-Review-85068.html>.
"Objective of Financial Statements- a Critical Review." StudyMode.com. 04, 2006. Accessed 04, 2006. http://www.studymode.com/essays/Objective-Financial-Statements-Critical-Review-85068.html.